EYA4 and breast carcinoma: Here, we demonstrate that EYA4 inhibits the expression of glycolytic genes, glucose uptake, and the production of lactate, pyruvate and ATP in liver cancer cells and breast cancer cells, suggesting that EYA4 is a repressor of glycolysis.